Previous close | 46.60 |
Open | 46.60 |
Bid | 49.00 |
Ask | 57.00 |
Strike | 520.00 |
Expiry date | 2026-12-18 |
Day's range | 46.60 - 46.60 |
Contract range | N/A |
Volume | |
Open interest | 2 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning